PharVision Advisers’s Arbor Realty Trust ABR Stock Holding History

PharVision Advisers’s Portfolio ABR Stock Details ABR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,955	Closed	-$207K	–	261
2024 Q4	$207K	Buy	+14,955	New	+$220K	0.18%	289

Other funds holding ABR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

PharVision Advisers's ABR Position: Q1 2025 in Review

PharVision Advisers sold out of Arbor Realty Trust (ABR) in Q1 2025, closing a stake of 14,955 shares — an estimated $207K sold.

PharVision Advisers first reported a position in ABR in Q4 2024 and held it in 1 quarter. The position peaked at $207K in Q4 2024. 331 funds tracked by Wall St. Rank hold ABR as of Q1 2025.

PharVision Advisers reported no remaining Arbor Realty Trust position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 14,955 Arbor Realty Trust shares in Q1 2025, an estimated $207K.
PharVision Advisers first reported a position in Arbor Realty Trust in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Arbor Realty Trust position peaked at $207K in Q4 2024.
331 funds tracked by Wall St. Rank held Arbor Realty Trust as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.